Zimmer Biomet Holdings Inc. lost its bid Friday to end fraud litigation over its acquisition of a soft tissue repair platform ...
The next generation of Zimmer Biomet’s Rosa Shoulder robot is in the works, CEO Ivan Tornos said in a first quarter earnings call. Zimmer Biomet’s Rosa Shoulder earned FDA approval and debuted in 2024 ...
Zimmer Biomet saw a strong first quarter, and U.S. growth in particular was bolstered by the hip franchise, CEO Ivan Tornos said in an earnings call. “Our U.S. hip franchise grew 5% in the quarter as ...
Zimmer Biomet is off to a strong start to 2026 but stopped short of raising guidance for the year. Here's what the CEO had to ...
Partial meniscectomy does not improve patient symptoms or function, reveals a 10-year follow-up of the FIDELITY, a ...
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2026. The Company reported first quarter net sales of $2.087 billion, an increase of 9 ...
Zimmer Biomet raised its 2026 adjusted earnings per share forecast to $8.40–$8.55, citing a strong first quarter and improved margins, while keeping its sales growth outlook unchanged at 1% to 3%. The ...
Zimmer Biomet (NYSE:ZBH) executives said the company began fiscal 2026 with organic constant-currency revenue at the high end ...
Dear R.L.: The menisci are cartilage structures inside the knee that provide support and shock absorption. They can be ...
Learn more Zimmer Biomet ZBH is set to release first-quarter 2026 results on April 28, before the market opens. The leading ...
Orthopedic surgeon Anthony Levenda, MD, is the first physician in Indiana to complete a procedure with the newest generation of the Misha knee system. The system is an implantable shock absorber ...
© Ricardo Moreira/Getty ImagesNeymar Junior of Santos looks on during the Brasileirao 2026 match. Even though the veteran has been impressing, Carlo Ancelotti is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results